Setmelanotide use in patients with BardetBiedel syndrome BBS is a rare ciliopathy characterized by a number of clinical features including retinal cone-rod dystrophy, polydactyly, cognitive impairment, renal disease, and early-onset obesity with hyperphagia
[DOI] [PubMed] [Google Scholar] 154.Roden M., Weng J., Eilbracht J., Delafont B., Kim G., Woerle H.J., Broedl U.C., EMPA-REG MONO Trial Investigators Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled, phase 3 trial
Additional information Edited by G Melino Supplemental Information accompanies the paper on the Cell Death Discovery website ( Supplementary information Rights and permissions This work is licensed under a Creative Commons Attribution 4.0 International License
In addition to Semaglutide, implementing dietary changes and increasing physical activity are crucial for achieving significant weight loss
Methods that can simultaneously detect dozens of peptides are becoming standard